Catalent has promoted its Australia Country General Manager, Mark Bisset, to President, Catalent Asia Pacific. He succeeds David Heyens who plans to retire on 31 December.
'Mark assumes his new role at an exciting time of expansion in the region and we welcome him to the Executive Leadership Team,' said John Chiminski, Catalent’s President and Chief Executive.
'We have made substantial investments in two joint ventures in China to serve our growing customer base there. Additionally, we are celebrating our 40th year in Japan with a new laboratory and the build-out of more manufacturing capacity, and are seeing strong market growth in these and other parts of the Asia Pacific region.'
Prior to joining Catalent, Bisset was Chief Executive for Strides Europe, leading all commercial and manufacturing activities across multiple countries while based in Poland. He had previously spent four years as Chief Operating Officer for Strides’ Australian and Asian businesses. Before that, he held global business development and product management roles with Mayne Pharma, Amrad Pharmaceuticals and Bristol Myers Squibb.
